Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: BSX stock price vs KW: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at KW's multiple
Needs KW P/E.
Implied fair value · at BSX's multiple
Needs EPS (TTM) is negative, BSX P/E.
Live quote
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: BSX FY 2025 (ended Dec 31, 2025) · KW FY 2025 (ended Dec 31, 2025).
Trendline
Ten fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
BOSTON SCIENTIFIC CORPORATION · implied price per share
Bear
$20.06
Base
$23.60
Bull
$27.14
Kennedy-Wilson Holdings, Inc. · implied price per share
Bear
-$3.32
Base
-$3.90
Bull
-$4.49
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.44x
2.87x
Net debt / EBITDA
Leverage against operating earnings
1.62x
7.99x
Cash and equivalents
Liquid reserves on the balance sheet
$1.97B
$192.00M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Abbott Laboratories
BSX vs ABT
Johnson & Johnson
BSX vs JNJ
Intuitive Surgical, Inc.
BSX vs ISRG
STRYKER CORP
BSX vs SYK
ZIMMER BIOMET HOLDINGS, INC.
BSX vs ZBH
Edwards Lifesciences Corp
BSX vs EW
CBRE GROUP, INC.
BSX vs CBRE
JONES LANG LASALLE INC
BSX vs JLL
SL GREEN REALTY CORP
BSX vs SLG
BXP, Inc.
BSX vs BXP
Four Corners Property Trust, Inc.
BSX vs FCPT
Empire State Realty Trust, Inc.
BSX vs ESRT
$10.75B
$4.40B
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
